| Literature DB >> 12865429 |
Ramesh Hegde1, Srinivasa M Srinivasula, Pinaki Datta, Muniswamy Madesh, Richard Wassell, ZhiJia Zhang, NaEun Cheong, Julie Nejmeh, Teresa Fernandes-Alnemri, Shin-ichi Hoshino, Emad S Alnemri.
Abstract
Smac/Diablo and HtrA2/Omi are inhibitors of apoptosis (IAP)-binding proteins released from the mitochondria of human cells during apoptosis and regulate apoptosis by liberating caspases from IAP inhibition. Here we describe the identification of a proteolytically processed isoform of the polypeptide chain-releasing factor GSPT1/eRF3 protein, which functions in translation, as a new IAP-binding protein. In common with other IAP-binding proteins, the processed GSPT1 protein harbors a conserved N-terminal IAP-binding motif (AKPF). Additionally, processed GSPT1 interacts biochemically with IAPs and could promote caspase activation, IAP ubiquitination and apoptosis. The IAP-binding motif of the processed GSPT1 is absolutely required for these activities. Our findings are consistent with a model whereby processing of GSPT1 into the IAP-binding isoform could potentiate apoptosis by liberating caspases from IAP inhibition, or target IAPs and the processed GSPT1 for proteasome-mediated degradation.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12865429 DOI: 10.1074/jbc.M303179200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157